Mesenchymal stem cells biological properties and possibilities of clinical use

Cover Page

Cite item

Full Text

Abstract

Autologic and allogeneic mesenchymal stem cells (MSC) transplantation currently is used in clinical practice for hematopoietic progenitor engraftment acceleration and graft versus host disease prophylactic and treatment. In this literature review data concerning efficacy, safety and technologies of MSC clinical use are analyzed. Biological properties of MSC received in long-term culture and mechanisms of their interaction with other cells are discussed.

About the authors

O. S. Tatarinova

Lomonosov Moscow state university

Moscow

Russian Federation

E. Yu. Osipova

Federal research center of pediatric hematology, oncology and immunology

Author for correspondence.
Email: e_ossipova@mail.ru

Moscow

Russian Federation

S. A. Roumiantsev

Federal research center of pediatric hematology, oncology and immunology

Moscow

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.